CSI Market
Sign In | Register

Heartsciences Inc (HSCS) Annual Cash Flow Statement

Annual · GAAP · USD millions
Access HSCS quarterly Cash Flow →
The cash flow figures below highlight longer-term patterns in how Heartsciences Inc manages cash inflows and outflows over time.
View historic periods: Download as CSV:
Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.
Annual Report, GAAP in USD millions
ITEM 		(Apr 30 2026)
12 Months 		(Apr 30 2025) (Apr 30 2024) (Apr 30 2023)
Operating Activities
Income-9.14
Depreciation & amortization0.03
Amortization of Other Assets0.50
Extraordinary Item, Gain (Loss), Insurance Assets, Accretion Expense0.00
Restructuring & Impairment Charges0.00
Provision For Loan Losses Expensed0.00
Increase (Decrease) in Inventories0.01
R & D, Environmental and Other Expense0.00
Gain (Loss) on Disposition of Assets0.00
Share-based Compensation1.42
Income (Loss) from Equity Method Investments0.00
Financial Instruments and Foreign Currency Transaction0.00
Operating Lease Right Of Use Asset Amortization Expense0.09
Increase Decrease In Operating Lease Liability-0.10
Increase Decrease In Capitalized Software-
Increase Decrease In Capitalized Software-
Income taxes0.00
Losses/ -gains on Investments net0.00
Increase (Decrease) in Accounts Receivable0.00
Increase (Decrease) in Accounts Payable0.00
Increase (Decrease) in Accrued Liabilities0.12
Deferred Revenue and Customer Advances and Deposits0.00
Increase (Decrease) in Prepaid Expense and Other Assets-0.24
Other Working Capital0.00
Other Noncash Income (Expense)0.00
Other net0.00
Payments for (Proceeds from) Other Operating Activities-0.11
Discontinued operations0.00
Net Cash flow from Operating Activities-7.43
Investing Activities
Capital Expenditures-0.04
Sale of Capital Items0.00
Short-term Investments Proceeds0.00
Short-term Investments Acq.0.00
Real Estate Investments0.00
Stock Issued-
Debt Conversion Converted Instrument Amount-
Conversion Of Stock Amount Issued-
Restricted Cash and Investments Increase (Decrease)0.00
Payments for (Proceeds from) Loans0.00
Payments for (Proceeds from) Deposits0.00
Payments for (Proceeds from) Other Investments0.00
Payments for (Proceeds from) Federal Reserve and FHLB0.00
Acquisition Net of Cash Acquired0.00
Interest in Subsidiaries and Affiliates0.00
Sale of businesses0.00
Accounts payable0.00
Receivables0.00
Payments for (Proceeds from) Other Investing Activities0.00
Other Net0.00
Discontinued operations0.00
Net Cash Flow from Investing Activities-0.04
Financing Activities
Short-term debt Net0.00
Other borrowing transactions0.00
Long-term debt - borrowings0.00
Long-term debt - repayments0.00
Federal Home Loan Bank and Federal Funds0.00
Issuances / -repurchases of Comm. Stock0.17
Partnership and Parent Transactions0.00
Issuances / -repurchases of Pref. Stock0.00
Deposits, Annuities, Contract Holders Funds0.00
Other financing activities net0.00
Other net7.86
Finance Lease Principal Payments-
Issuance Of Common Stock For Exercise Of Pre Funded Warrants-
Issuance Of Common Stock Under Equity Line Net Of Fees1.15
Proceeds From Issuance Of Common Stock Under A T M Facilty Net Of Fees-
Principal Repayments Of Operating Lease Obligations-0.26
Repayment Of Financed Insurance Premiums-
Proceeds From Issuance Of Preferred Stock And Warrants-
Repayments Of Financed Insurance Premiums-
Payments of Dividends, Preferred Stock and Preference Stock0.00
Dividends paid0.00
Net Cash Flow from Financing Activities8.03
Effect of exchange rate on cash flow0.00
Discontinued operations0.00
Free Cash Flow-7.47
Total Cash Flow0.56
4 historic quarters locked

Sign in to unlock the full Heartsciences Inc cash flow history.

Sign In Create Free Account

About Heartsciences Inc Annual Cash Flow Statement

What this statement shows

This page presents issuer-reported cash flow data, including operating, investing, financing, net, and free cash flow, as disclosed in SEC 10-K filings and normalized by CSIMarket.

Source & verification

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - normalization in the CSIMarket.com database.
  • Accession: 0001437749-26-024337

Figures are derived from filed reports and may be restated. Historical data is subject to revision.

Untitled Document 





                    


    



  Get the full CSIMarket dataset:
  Subscribe
  API
  License